Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoma, Islet Cell × Radiofrequency Ablation × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Nodule 4 Thyroid Neoplasms 3 Pain 2 Agnosia 2 Thyroid Cancer, Papillary 1 Prostatic Neoplasms 1 Neuroma 1 Neuralgia 1 Neoplasm Metastasis 1 Myoma 1 Multiple Advanced Tumors After PD-1 Therapy Failure 1 Multi-organ Metastatic Colorectal Cancer 1 Menorrhagia 1 Lymphatic Metastasis 1 Leiomyoma 1 Klatskin Tumor 1 Hypesthesia 1 Hyperthyroidism 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Medullary 1 Breast Neoplasms 1 Breast Cancer Female 1 Bile Duct Neoplasms 1 Barrett Esophagus 1 Adenoma, Islet Cell 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

lutetium Lu 177 dotatate 3 Temozolomide 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Capecitabine 3 Sunitinib 2 Octreotide 2 Everolimus 2 sargramostim 1 sapanisertib 1 montanide ISA 51 1 lanreotide 1 incomplete Freund's adjuvant 1 fludarabine phosphate 1 cabozantinib 1 belzutifan 1 atezolizumab 1 aflibercept 1 abemaciclib 1 X-Rays 1 Salts 1 Radiofrequency Ablation 1 Phantoms, Imaging 1 PM 01183 1 LY2940680 1 Interleukin-13 1 Injections 1 Immunoglobulin G 1 Fulvestrant 1 Fluorodeoxyglucose F18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04520932 2025-05-25

RFANET

Institut Paoli-Calmettes

Phase NA Recruiting

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡